ArticleEuropean child & adolescent psychiatry2026
Risk factors for developmental delays in small for gestational age children at age of 24-36 months.
Article in European child & adolescent psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Long-term neurodevelopmental/socioemotional risks in small for gestational age (SGA) children lack robust evidence, especially maternal/neonatal predictors. The study aims to identify independent maternal and neonatal risk factors associated with atypical neurodevelopmental and socioemotional outcomes in SGA children. This longitudinal cohort study included 412 singleton SGA infants born at Peking University People's Hospital in Beijing from January 2020 to December 2022. Participants underwent 24-36 months follow-up median 30 months, with neurodevelopmental and socioemotional outcomes evaluated using the Ages and Stages Questionnaires, Third Edition (ASQ-3) and Ages and Stages Questionnaires: Social-Emotional (ASQ: SE). These assessments categorized SGA children into normal/atypical development groups for both domains. Through assessment, there were 292 cases (70.9%) of development on track SGA children. The atypical neurodevelopment group included 92 cases (22.3%), among which 38 cases (9.2%) exhibited atypical development in one domain and 54 cases (13.1%) in ≥ 2 domains. The atypical socioemotional development group included 48 cases (11.7%). Additionally, 20 cases (4.9%) of SGA children exhibited both atypical neurodevelopment and atypical socioemotional development. Multivariable regression analysis showed that maternal pre-pregnancy underweight (OR = 6.93, 95% CI = 2.76-17.41), maternal inadequate gestational weight gain (GWG) (OR = 4.63, 95% CI = 2.15-9.99), maternal excessive GWG (OR = 2.51, 95% CI = 1.14-5.55), preterm infant (OR = 1.26, 95% CI = 1.03-1.55), severe SGA (OR = 2.95, 95% CI = 1.47-5.90) and neonatal respiratory distress syndrome Peking University People's Hospital (OR = 1.29, 95% CI = 1.06-1.57) were independently related to the occurrence of atypical neurodevelopment outcomes in SGA children; maternal pre-pregnancy underweight (OR = 3.54, 95% CI = 1.11-7.27), maternal inadequate GWG (OR = 3.60, 95% CI = 1.32-8.84), preterm infant (OR = 3.08, 95% CI = 1.09-7.17) and male (OR = 2.23, 95% CI = 1.05-4.75) were independently related to the occurrence of atypical socioemotional development in SGA children. Monitoring and promoting of maternal appropriate weight gain or the maternal health would improve outcome of SGA infants.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.